TORPENZ
Live / Registered — Registered (as of 14 Oct 2025)
What this means for you
Registered since 14 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98126977
- Registration number
- 7986412
- Mark type
- Stylized text
- Filed
- 10 Aug 2023
- Published for opposition
- 12 Mar 2024
- Registered
- 14 Oct 2025
- Attorney of record
- Makiko Coffland
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of kidney diseases and disorders; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the immune system and for use in transplantation; pharmaceutical preparations for the prevention and treatment of rare and orphan diseases and disorders; pharmaceutical preparations for the treatment of Tuberous Sclerosis Complex (TSC)
Owner
- Upsher-Smith Laboratories, LLC, Maple Grove, MN, US
- Upsher-Smith Laboratories, LLC, Maple Grove, MN, US
- Upsher-Smith Laboratories, LLC, Maple Grove, MN, US
Prosecution history
- 14 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 24 Sept 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Sept 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Aug 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Aug 2024 — USE AMENDMENT FILED
- 08 Aug 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Aug 2024 — TEAS STATEMENT OF USE RECEIVED
- 07 May 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Mar 2024 — PUBLISHED FOR OPPOSITION
- 21 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jan 2024 — ASSIGNED TO EXAMINER